USPTO serial 88291660
ECHOGO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 13, 2020
- Examiner
- QUEEN, ESTHER FELICIA
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with ECHOGO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,097*
Plus Government fees of $1,275
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
N. Alexander Nolte
N. Alexander Nolte Nolte Lackenbach Siegel111 Brook Street Suite 101Scarsdale, NY 10583United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | downloadable software for operating and managing databases in the field of cardiology; recorded software for operating and managing databases in the field of cardiology; downloadable software for operating and managing data banks in the field of cardiology; recorded software for operating and managing data banks in the field of cardiology; downloadable software for use in medical diagnosis, namely, for analyzing medical data to assist in providing clinical interpretations; recorded software for use in medical diagnosis, namely, for analyzing medical data to assist in providing clinical interpretations; application software for handheld computers, namely, downloadable software for use in medical diagnosis, namely, for analyzing medical data to assist in providing clinical interpretations; application software for handheld computers, namely, recorded software for use in medical diagnosis, namely, for analyzing medical data to assist in providing clinical interpretations; downloadable computer software for use in medical diagnosis, namely, for analyzing medical data to assist in providing clinical interpretations; recorded computer software for use in medical diagnosis, namely, for analyzing medical data to assist in providing clinical interpretations; downloadable software applications for use in medical diagnosis, namely, for analyzing medical data to assist in providing clinical interpretations; recorded software applications for use in medical diagnosis, namely, for analyzing medical data to assist in providing clinical interpretations; software relating to data analytics being downloadable software for analyzing patient data from medical patient monitoring and diagnostic equipment; software relating to data analytics being recorded software for analyzing patient data from medical patient monitoring and diagnostic equipment; downloadable artificial intelligence software for use in medical diagnosis, namely, for analyzing medical data to assist in providing clinical interpretations; recorded artificial intelligence software for use in medical diagnosis, namely, for analyzing medical data to assist in providing clinical interpretations; downloadable software for use in medical diagnosis, namely, for interpreting the results of echocardiograms; recorded software for use in medical diagnosis, namely, for interpreting the results of echocardiograms; echocardiography software being downloadable software for interpreting the results of echocardiograms; echocardiography software being recorded software for interpreting the results of echocardiograms; all of the aforesaid goods relating to or connected with the identification, imaging, diagnosis and treatment of cardiovascular conditions and coronary heart disease | ACTIVE | — |
| 042 | Research and development services in the field of cardiology; medical research and development services in the field of cardiology; scientific research and development services; pharmaceutical research and development services; design services, namely, medical diagnostic apparatus and instrument design services; research, design and development of medical apparatus and instruments; research, design and development of medical diagnostic apparatus and instruments; research, design and development of cardiovascular diagnostic testing apparatus and instruments; product design, research and development services in the field of artificial intelligence related to the field of medicine, medical diagnosis and cardiology; design, research, development, maintenance, updating, testing, customisation, implementation, installation and rental of software, computer software, software programs, application software and software applications in the field of cardiology; technical support being software programming, installation, and advisory and information services in the field of software programming and installation in the field of medicine, medical diagnosis and cardiology; maintenance and repair services for software, computer software, application software and software applications in the field of medicine, medical diagnosis and cardiology; software as a service (SAAS) services featuring software for use in the field of medicine and medical diagnosis, namely, for analyzing medical data to provide suggested clinical interpretations for medical diagnosis purposes; cloud computing services, namely, cloud hosting provider services in the field of medicine, medical diagnosis and cardiology; all of the aforesaid services relating to or connected with the identification, imaging, diagnosis and treatment of cardiovascular conditions and coronary heart disease | ACTIVE | — |
| 044 | Medical services; medical diagnostic services; medical imaging services; providing medical information to medical professionals in the form of medical reports in the field of cardiology; medical screening relating to the heart; medical services, namely, medical testing, screening and analysis for diagnostic and treatment purposes; medical services, namely, medical testing, screening and analysis services relating to the diagnosis and treatment of disease; medical services, namely, medical testing, screening and analysis services relating to the diagnosis and treatment of cardiovascular disease; all of the aforesaid services relating to or connected with the identification, imaging, diagnosis and treatment of cardiovascular conditions and coronary heart disease | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Ultromics Limited
- Other trademarks owned by Ultromics Limited
- Other trademarks owned by Ultromics Limited
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ECHOGO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 29, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 24, 2026 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Jul 13, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 13, 2026 | EWOR | TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED | — |
| Jul 13, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 13, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jul 13, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Jul 13, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 13, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Mar 24, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 24, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 24, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Mar 24, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 24, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 24, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Oct 13, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 4, 2020 | ISPO | WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST | — |
| Aug 3, 2020 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Jul 28, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 28, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 8, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 21, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 18, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 18, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 18, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 18, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 22, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 22, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 22, 2020 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 21, 2020 | DMCC | DATA MODIFICATION COMPLETED | — |
| Mar 31, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 31, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 31, 2020 | ERSI | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | — |
| Nov 25, 2019 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Nov 25, 2019 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Nov 25, 2019 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Nov 4, 2019 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 4, 2019 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 30, 2019 | ALIE | ASSIGNED TO LIE | — |
| Oct 23, 2019 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 23, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 23, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 23, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 18, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 28, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 9, 2019 | NWAP | NEW APPLICATION ENTERED | — |